PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier
The September issue of The Journal of Nuclear Medicine published a study that shows that positron emission tomography (PET)/computer tomography (CT) scans using the imaging agent choline could detect recurring prostate cancer sooner than conventional [...]
The Name of The Game Is Life Extension
Advanced prostate cancer will progress and most of us will face a time when Androgen Deprivation Therapy (ADT) stops working. Most men on ADT take a LHRH agonist, which turns off the production of testosterone [...]
The Cancer Journey
A man at one of my support groups asked if I could go back in time would I repeat my journey with cancer? I first thought was this a stupid question; of course, I would [...]
C-Reactive Protein as Adverse Prognostic Marker for Men with Castration-Resistant Prostate Cancer
A confirmatory study evaluating the prognostic value of C-reactive protein (CRP) levels in men with castrate-resistant prostate cancer (CRPC) was presented at the 2009 American Society of Clinical Oncology (ASCO) conference in Orlando Florida. Historically, [...]
Factors Pointing to the Development of Metastatic Prostate Cancer
It is inevitable; most men with prostate cancer, who require treatment with androgen deprivation therapy (ADT), will eventually become resistance to treatment leading to the development of metastatic disease. Men who develop metastatic castrate-resistant disease [...]
Carboplatin-Taxane Combinations in the Management of Castration-resistant Prostate Cancer
The use of Docetaxel (chemotherapy) extends survival time in men with castration-resistant prostate cancer (CRPC). Many researchers believe that platinum compounds, particularly Carboplatin, when added to docetaxel (taxane-based chemotherapy) can further extend survival times. A [...]